|
Jeffrey Long-McGie is a Healthcare Analyst at Ridgeback Capital Management. Jeff’s business experience includes positions of Vice President of Business Development at Andrx Pharmaceuticals and Andrx Therapeutics. Jeff’s investment experience includes positions at ThinkEquity and A.G. Edwards where he was responsible for coverage of the generic pharmaceutical industry. His educational background includes an MBA from Saint Louis University, a Master’s in Biology from Washington University and a BS in Microbiology from California State University. Currently, Jeff serves as a member of the Finance Committee for the Food and Drug Law Institute. Additionally, Jeff has served as a Consultant for multiple pre-IPO stage Pharmaceutical Companies. | 